Efficacy of Brentuximab Vedotin and Other Treatments in Patients with Relapsed or Refractory (RR) Systemic Anaplastic Large-Cell Lymphoma (SALCL)- A Systematic Review

Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.416
https://www.valueinhealthjournal.com/article/S1098-3015(13)02321-8/fulltext
Title : Efficacy of Brentuximab Vedotin and Other Treatments in Patients with Relapsed or Refractory (RR) Systemic Anaplastic Large-Cell Lymphoma (SALCL)- A Systematic Review
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02321-8&doi=10.1016/j.jval.2013.08.416
First page : A395
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 399
Categories :
Tags :
Regions :
ViH Article Tags :